Follow
Akitsu Hotta, Ph.D.
Akitsu Hotta, Ph.D.
Center for iPS Cell Research & Application (CiRA), Kyoto University
Verified email at cira.kyoto-u.ac.jp - Homepage
Title
Cited by
Cited by
Year
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines
SJ Kattman, AD Witty, M Gagliardi, NC Dubois, M Niapour, A Hotta, J Ellis, ...
Cell stem cell 8 (2), 228-240, 2011
13812011
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9
HL Li, N Fujimoto, N Sasakawa, S Shirai, T Ohkame, T Sakuma, ...
Stem cell reports 4 (1), 143-154, 2015
6582015
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility
H Xu, BO Wang, M Ono, A Kagita, K Fujii, N Sasakawa, T Ueda, P Gee, ...
Cell stem cell 24 (4), 566-578. e7, 2019
4742019
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency
A Hotta, AYL Cheung, N Farra, K Vijayaragavan, CA Séguin, JS Draper, ...
Nature methods 6 (5), 370-376, 2009
3782009
Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a nonhuman primate
A Morizane, D Doi, T Kikuchi, K Okita, A Hotta, T Kawasaki, T Hayashi, ...
Stem cell reports 1 (4), 283-292, 2013
3172013
Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation
AYL Cheung, LM Horvath, D Grafodatskaya, P Pasceri, R Weksberg, ...
Human molecular genetics 20 (11), 2103-2115, 2011
3072011
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
P Gee, MSY Lung, Y Okuzaki, N Sasakawa, T Iguchi, Y Makita, H Hozumi, ...
Nature communications 11 (1), 1334, 2020
2792020
Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
A Tanaka, K Woltjen, K Miyake, A Hotta, M Ikeya, T Yamamoto, T Nishino, ...
PloS one 8 (4), e61540, 2013
2552013
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
K Imamura, Y Izumi, A Watanabe, K Tsukita, K Woltjen, T Yamamoto, ...
Science Translational Medicine 9 (391), eaaf3962, 2017
2522017
Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type
W Rahmani, S Abbasi, A Hagner, E Raharjo, R Kumar, A Hotta, ...
Developmental cell 31 (5), 543-558, 2014
2442014
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states
A Hotta, J Ellis
Journal of cellular biochemistry 105 (4), 940-948, 2008
2212008
Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model
IY Choi, HT Lim, K Estrellas, J Mula, TV Cohen, Y Zhang, CJ Donnelly, ...
Cell reports 15 (10), 2301-2312, 2016
1732016
Constitutive heterochromatin reorganization during somatic cell reprogramming
E Fussner, U Djuric, M Strauss, A Hotta, C Perez‐Iratxeta, F Lanner, ...
The EMBO journal 30 (9), 1778-1789, 2011
1732011
CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
H Morisaka, K Yoshimi, Y Okuzaki, P Gee, Y Kunihiro, E Sonpho, H Xu, ...
Nature communications 10 (1), 5302, 2019
1662019
Evolutionarily distinctive transcriptional and signaling programs drive human germ cell lineage specification from pluripotent stem cells
Y Kojima, K Sasaki, S Yokobayashi, Y Sakai, T Nakamura, Y Yabuta, ...
Cell stem cell 21 (4), 517-532. e5, 2017
1652017
Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice
T Kondo, M Funayama, K Tsukita, A Hotta, A Yasuda, S Nori, S Kaneko, ...
Stem cell reports 3 (2), 242-249, 2014
1622014
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
E Kenjo, H Hozumi, Y Makita, KA Iwabuchi, N Fujimoto, S Matsumoto, ...
Nature communications 12 (1), 7101, 2021
1522021
Enhancing T cell receptor stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy
A Minagawa, T Yoshikawa, M Yasukawa, A Hotta, M Kunitomo, S Iriguchi, ...
Cell Stem Cell 23 (6), 850-858. e4, 2018
1432018
From genomics to gene therapy: induced pluripotent stem cells meet genome editing
A Hotta, S Yamanaka
Annual review of genetics 49 (1), 47-70, 2015
1422015
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
EA Taha, J Lee, A Hotta
Journal of Controlled Release 342, 345-361, 2022
1342022
The system can't perform the operation now. Try again later.
Articles 1–20